AGM Statement ...
17 Novembre 2015 - 8:00AM
UK Regulatory
/**/
RNS Number : 9153F
Craneware plc
17 November 2015
Craneware plc
("Craneware" or the
"Company")
AGM Statement
17
November 2015 - Craneware plc (AIM: CRW.L), the leader in Value Cycle
solutions for the US healthcare market, will be holding its Annual
General Meeting today at 9am. At the
meeting, Keith Neilson, CEO of the Company, will make the following
statement:
"We have experienced a positive
start to trading in the first few months of the year. In June, we
launched the Value Cycle, our vision for the
process and culture by which healthcare providers pursue quality
patient outcomes and optimal financial performance within a
healthcare market moving towards value-based care. Our leadership
in this area has further strengthened Craneware's position
as a trusted partner for US healthcare organisations as they look
to solve the challenges of the new value based reimbursement
models.
This positive impact of the Value
Cycle on the level of sales activity combined with the contribution of the prior year's sales
flowing through to the current year financial results and the
continued high levels of cash generation, mean we are well
positioned to continue to execute on our growth
strategy."
Craneware will be hosting an analyst
and investor presentation at 11am today. The presentation to be
given at the meeting will cover topics including the evolution of
the US healthcare market towards value-based care, the escalation
of patient engagement and consumerism, and the Value Cycle. The
presentation will contain no new material information.
Copies of the presentation will be
made available on the Company's website at www.craneware.com.
For further information, please
contact:
Craneware plc
|
Peel
Hunt
|
Alma
|
+44 (0)131 550 3100
|
+44 (0)20 7418 8900
|
+44 (0)7515 805 218
|
Keith Neilson, CEO
|
Dan Webster
|
Caroline Forde
|
Craig Preston, CFO
|
Richard Kauffer
|
|
About Craneware
Craneware is the leader in
automated value cycle solutions that help US provider
organisations discover, convert and optimise assets to achieve best
clinical outcomes and financial performance. Founded in
1999, Craneware has headquarters in Edinburgh, Scotland with
offices in Atlanta, Boston, Nashville and Phoenix employing over
200 staff. Craneware's market-driven, SaaS
solutions normalise disparate data sets, bringing in
up-to-date regulatory and financial compliance data to deliver
value at the points where clinical and operational data
transform into financial transactions, creating actionable insights
that enable informed tactical and strategic decisions. To learn
more, visit craneware.com and thevaluecycle.com.
This information is provided by RNS
The company news service from the
London Stock Exchange
END
AGMBCBDBUGBBGUL
Grafico Azioni Craneware (LSE:CRW)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni Craneware (LSE:CRW)
Storico
Da Lug 2023 a Lug 2024